glutathione and radiation protection cancer Frontiers Antioxidants in cancer therapy mitigating

Key variants in FTO (rs9939609), MC4R (rs17782313), and GIPR (rs1800437) reveal how your body regulates appetite, energy expenditure, and satiety signaling

Several studies suggest that ALA is an agonist of PPAR, promoting increased mitochondrial biogenesis, OCR, and the expression of transcription factors such as PGC1 and NRF2 [83, 84]

often describing the primordial substance from which all things come and return to

20 Nrf2 and cancer risk Additionally, mutations in the Nrf2 gene in human studies have been associated with an increased risk of cancer, with the authors proposing that constance Nrf2 activity, prevents anti-cancer targeted oxidative stress, allowing cancer cells to survive